Clinical Trials Logo

Filter by:
NCT ID: NCT05815147 Recruiting - Sleep Clinical Trials

An Exploratory Real-world Study to Explore the Effects of Fortified Powdered Beverage on Sleep Quality in Chinese Adults With Mild Sleep Issue(s) or Complaint(s)

Start date: July 21, 2023
Phase: N/A
Study type: Interventional

The goal of this exploratory study is to explore the sleep and related health benefits of the study product in Chinese middle-aged & elderly population in real world settings and potentially generate hypothesis on key exploratory and other exploratory objectives. The main questions it aims to answer are: - To explore the effects of test product on sleep quality; - To understand and evaluate effects of test product on sleep pattern; - To assess the subjects' overall health status self-evaluation. etc. Participants will be asked to take study product, collect the sleep pattern parameters and report the overall health status.

NCT ID: NCT05815082 Recruiting - Colorectal Cancer Clinical Trials

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

Start date: February 20, 2023
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to compare in resectable colorectal cancer liver metastasis patients.The main question it aims to answer is whether the 3-year progression-free survival rate (PFS) of "watching and waiting" is non-inferior to adjuvant chemotherapy in postoperative ctDNA-negative resectable colorectal cancer liver metastasis patients.Participants will undergo ctDNA testing after resection of colorectal cancer liver metastasis, and will be randomly assigned to receive adjuvant chemotherapy or "watching and waiting" treatment strategy. The researchers will compare the outcomes between the two groups to see if the PFS between the two groups is similar.

NCT ID: NCT05815069 Recruiting - Clinical trials for Aldosterone-Producing Adenoma

[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism

Start date: January 7, 2023
Phase: N/A
Study type: Interventional

The study was proposed to include 20 patients with clinical suspicion of primary aldosteronism for [18F]AlF-NOTA-pentixather PET/CT imaging and to analyze the specificity and sensitivity of [18F]AlF-NOTA-pentixather PET/CT for the diagnosis of APA by comparison with the final pathological findings.

NCT ID: NCT05814952 Recruiting - Clinical trials for X-linked Retinoschisis

Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)

Start date: December 13, 2022
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the safety and efficacy of LX103 treatment of X-linked retinoschisis. This study will enroll subjects aged ≥ 6 years old to receive a single unilateral intravitreal (IVT) injection of LX103 to evaluate its safety and efficacy.

NCT ID: NCT05814939 Recruiting - Clinical trials for Active Ankylosing Spondylitis

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Start date: April 26, 2023
Phase: Phase 2
Study type: Interventional

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.

NCT ID: NCT05814926 Completed - Healthy Volunteers Clinical Trials

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Start date: April 26, 2023
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to test whether mild (Child-Pugh A, score 5-6) and moderate (Child-Pugh B, score 7-9) hepatic impairment affects pharmacokinetics, safety and tolerability of GP681, compared with a control group with normal hepatic function following oral administration of GP681 as single dose.

NCT ID: NCT05814835 Completed - Clinical trials for Malignant Solid Tumors

First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

Start date: December 7, 2022
Phase: Phase 1
Study type: Interventional

This is the first-in-human study of 68Ga/64Cu-FAPI-XT117, which is an prospective, single-arm phase I clinical study.

NCT ID: NCT05814731 Not yet recruiting - Conditioning Clinical Trials

Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

Start date: April 15, 2023
Phase: N/A
Study type: Interventional

According to the 2022 ELN guidelines patients with high-risk acute myeloid leukemia were randomly divided into MA-BUCY2 conditioning group and BuCy2 conditioning group,to evaluate the efficacy and safety of two conditioning regimens in haploidentical hematopoietic stem cell transplantation.

NCT ID: NCT05814718 Not yet recruiting - Conditioning Clinical Trials

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

Start date: April 15, 2023
Phase: N/A
Study type: Interventional

A multicenter randomized study on the efficacy and safety of mitoxantrone hydrochloride liposome injection combined with carmustine, etoposide, and cytarabine (modified BEAM protocol) in the pretreatment of T-cell lymphoma underwent autologous stem cell transplantation

NCT ID: NCT05814640 Recruiting - Depression Clinical Trials

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

STAR-AD
Start date: February 20, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This project aims to investigate the effectiveness of existing common antidepressants and to provide new evidence for depressed children and adolescents who are not responding to their first treatment.